---
pmid: '16407292'
title: Hepatic PCSK9 expression is regulated by nutritional status via insulin and
  sterol regulatory element-binding protein 1c.
authors:
- Costet P
- Cariou B
- Lambert G
- Lalanne F
- Lardeux B
- Jarnoux AL
- Grefhorst A
- Staels B
- Krempf M
journal: J Biol Chem
year: '2006'
full_text_available: false
doi: 10.1074/jbc.M508582200
---

# Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c.
**Authors:** Costet P, Cariou B, Lambert G, Lalanne F, Lardeux B, Jarnoux AL, Grefhorst A, Staels B, Krempf M
**Journal:** J Biol Chem (2006)
**DOI:** [10.1074/jbc.M508582200](https://doi.org/10.1074/jbc.M508582200)

## Abstract

1. J Biol Chem. 2006 Mar 10;281(10):6211-8. doi: 10.1074/jbc.M508582200. Epub
2006  Jan 6.

Hepatic PCSK9 expression is regulated by nutritional status via insulin and 
sterol regulatory element-binding protein 1c.

Costet P(1), Cariou B, Lambert G, Lalanne F, Lardeux B, Jarnoux AL, Grefhorst A, 
Staels B, Krempf M.

Author information:
(1)INSERM, U539, CHU HÃ´tel Dieu, 44000, Nantes, France. 
philippe.costet@univ-nantes.fr

Familial autosomal dominant hypercholesterolemia is associated with high risk 
for cardiovascular accidents and is related to mutations in the low density 
lipoprotein receptor or its ligand apolipoprotein B (apoB). Mutations in a third 
gene, proprotein convertase subtilisin kexin 9 (PCSK9), were recently associated 
to this disease. PCSK9 acts as a natural inhibitor of the low density 
lipoprotein receptor pathway, and both genes are regulated by depletion of 
cholesterol cell content and statins, via sterol regulatory element-binding 
protein (SREBP). Here we investigated the regulation of PCSK9 gene expression 
during nutritional changes. We showed that PCSK9 mRNA quantity is decreased by 
73% in mice after 24 h of fasting, leading to a 2-fold decrease in protein 
level. In contrast PCSK9 expression was restored upon high carbohydrate 
refeeding. PCSK9 mRNA increased by 4-5-fold in presence of insulin in rodent 
primary hepatocytes, whereas glucose had no effect. Moreover, insulin 
up-regulated hepatic PCSK9 expression in vivo during a 
hyperinsulinemic-euglycemic clamp in mice. Adenoviral mediated overexpression of 
a dominant or negative form of SREBP-1c confirmed the implication of this 
transcription factor in insulin-mediated stimulation of PCSK9 expression. Liver 
X receptor agonist T0901317 also regulated PCSK9 expression via this same 
pathway (a 2-fold increase in PCSK9 mRNA of primary hepatocytes cultured for 24 
h in presence of 1 microm T0901317). As our last investigation, we isolated 
PCSK9 proximal promoter and verified the functionality of a SREBP-1c responsive 
element located from 335 bp to 355 bp upstream of the ATG. Together, these 
results show that PCSK9 expression is regulated by nutritional status and 
insulinemia.

DOI: 10.1074/jbc.M508582200
PMID: 16407292 [Indexed for MEDLINE]
